A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo

International Immunopharmacology

Volumn 8, Issue 6, 2008, Pages 775-781

  Ren, Jian Dong ^a   Gu, Jin Song ^a   Gao, Hong Fu ^a   Xia, Pei Yuan ^a   Xiao, Guang Xia ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxin neutralization; Limulus anti lipopolysaccharide factor; Lipopolysaccharide; Septic shock

Indexed keywords

CYCLIC PEPTIDE 19; CYCLOPEPTIDE; ENDOTOXIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; ASSAY; BINDING AFFINITY; BIOSENSOR; DETOXIFICATION; DRUG ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIMULUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SYNTHESIS;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; HORSESHOE CRABS; INVERTEBRATE HORMONES; LIMULUS TEST; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED STRAINS; PEPTIDES, CYCLIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43049115316     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.015     Document Type: Article

References (23)

1. Crawford J.H., Yang S., Zhou M., Simms H.H., and Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit Care Med 32 (2004) 502-508
2. Mora P., Mas-Moruno C., Tamborero S., Cruz L.J., Perez-Paya E., and Albericio F. Design of a minimized cyclic tetrapeptide that neutralizes bacterial endotoxins. J Pept Sct 12 (2006) 491-496
3. Rustici A., Velucchi M., Faggioni R., Sironi M., Ghezzi P., Quataert S., et al. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 259 (1993) 361-365
4. Zheng J., Zhou H., Wei G., Gong X.Y., Lu G.F., Lu Y.L., et al. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo. Int Immunol 4 (2004) 527-537
5. Hirata M., Shimomura Y., Yoshida M., Morgan J.G., Palings I., Wilson D., et al. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Prog Clin Biol Res 388 (1994) 147-159
6. Guo Y.B., Zheng J., Zhou H., Lv G.F., Wang L.X., Wei G., et al. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro. Biochem Pharm 70 (2005) 209-219
7. Taylor A.H., Heavner G., Nedelman M., Sherris D., Brant E., Knight D., et al. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J Biol Chem 270 (1995) 17934-17938
8. Ried C., Wahl C., Miethke T., Wellnhofer G., Landgraf C., Schneider-Mergener J., et al. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor. J Biol Chem 27 (1996) 28120-28127
9. Kloczewiak M., Black K.M., Loiselle P., Cavaillon J.M., Wainwright N., and Warren H.S. Synthetic peptides that mimic the binding site of horseshoe crab anti-lipopolysaccharide factor. J Infect Dis 170 (1994) 1490-1497
10. Vallespi M.G., Glaria L.A., Reyes O., Garay H.E., Ferrero J., and Arana M.J. A Limulus anti-lipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases. Clin Diagn Lab Immunol 7 (2000) 669-675
11. Vallespi M.G., Alvarez-Obreqon J.C., Rodriquez-Alonso I., Montero T., Garay H., Reyes O., et al. A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice. Int Immunopharmacol 3 (2003) 247-256
12. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., et al. Diagnostic value of procalcitonin, interleukin-6, and nterleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164 (2001) 396-402
13. Lipford G.B., Sparwasser T., Bauer M., Zimmermann S., Koch E.S., Heeg K., et al. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol 27 (1997) 3420-3426
14. Yao Y.M., Redl H., Bahrami S., and Schlag G. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res 47 (1998) 201-210
15. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanism of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437-457
16. Brandenburg K., Jurgens G., Muller M., Fukuoka S., and Koch M.H. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem 382 (2001) 15-25
17. Larrick J.W., Hirata M., Balint R.F., Lee J., Zhong J., and Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63 (1995) 1291-1297
18. Mayumi T., Takezawa J., Takahashi H., Kuwayama N., Fukuoka T., Shimizu K., et al. Low-dose intramuscular polymyxin B improves survival of sepsis rats. Shock 11 (1999) 82-86
19. Scott M.G., Vreugdenhil A.C., Buurman W.A., Hancock R.E., and Gold M.R. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164 (2000) 549-553
20. Arana Mde J., Vallespi M.G., Chinea G., Vallespi G.V., Rodriguez-Alonso I., Garay H.E., et al. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. J Endotoxin Res 9 (2003) 281-291
21. Nagaoka I., Hirota S., Niyonsaba F., Hirata M., Adachi Y., Tamura H., et al. Augmentation of the lipopolysaccharide neutralizing activities of human cathelicidin CAP18 LL-37 derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 9 (2002) 972-982
22. Bohrer D., Horner R., do Nascimento P.C., Adaime M., Pereira M.E., Martins A.F., et al. Interference in the Limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis. J Pharm Biomed Anal 26 (2001) 811-818
23. Hartung T., Fennrich S., Fischer M., Montag-Lessing T., and Wendel A. Development and evaluation of a pyrogen test based on human whole blood. ALTEX 15 (1998) 9-10